# Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

> **NCT01156298** · — · TERMINATED · sponsor: **Biogen** · enrollment: 383 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01156298
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 383 (ESTIMATED)
- **Why stopped:** low enrollment
- **Last updated:** 2012-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156298, "Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01156298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*